Early Options - A Provider's Guide to Medical Abortion Early Options - A Provider's Guide to Medical Abortion Early Options - A Provider's Guide to Medical Abortion
Home
Information About the Early Options Program
CME Information
Women's Experiences: Video Clips
Video Help
Back to prochoice.org
National Abortion Federation
References - Medical Abortion Service Delivery

  1. Mifeprex® prescribing information. Danco Laboratories LLC; Rev2: 7/19/05. Available at http://earlyoptionpill.com/pdfs/prescribing071905.pdf (PDF file, 191K).
     
  2. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone. J Fam Pract. 1997;44:353-360.
     
  3. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 1999;59:1-6.
     
  4. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception. 2000;61:41-46.
     
  5. Schaff EA, Fielding SL, Westhoff C, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. JAMA. 2000;284:1948-1953.
     
  6. Creinin MD, Vittinghoff E, Schaff E, Klaisle C, Darney PD, Dean C. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol. 1997;90:611-616.
     
  7. Schaff EA, Eisinger SH, Franks P, Kim SS. Methotrexate and misoprostol for early abortion. Fam Med. 1996;28:198-203.
     
  8. Breitbart V, Repass DC. The counseling component of medical abortion. J Am Med Women Assoc. 2000;55(suppl 3):164-166.
     
  9. Randall L, Runkle A. Measuring surgical and medication abortion services productivity at Planned Parenthood. Paper presented at the National Abortion Federation 29th Annual Meeting, Montreal, April 2005.
     
  10. Gould H, Stewart F, Weitz T, Phillips K, Van Bebber S, et al. Lessons learned from a study of medication abortion service delivery costs in 10 U.S. practice settings. Paper presented at the National Abortion Federation 29th Annual Meeting, Montreal, April 2005.
     
  11. Hern WM. Abortion Practice. Philadelphia, Pa: JB Lippincott Co; 1984.
     
  12. Picardo L, Singh D, Westhoff C. Mifepristone versus Manual Vacuum Aspiration: Personnel Costs and Quality of Life Comparisons [NAF poster presentation]. 2000.
     
  13. Guttmacher Institute. State Policies in Brief: Abortion Reporting Requirements. July 2005. Available at www.guttmacher.org/statecenter/spibs/spib_ARR.pdf
     
  14. Jones RK, Henshaw SK. Mifepristone for early medical abortion: Experiences in France, Great Britain, and Sweden. Persp Sexual Repro Hlth 2002;34(3):154-161.
     
  15. Planned Parenthood Consortium of Abortion Providers. Mife Matters Fall 2003; 8: 5.

 
Click here to return to Module 5 - Medical Abortion Service Delivery.

©2009 Copyright National Abortion Federation
Disclaimer | Contact Us